iRadimed Corporation (IRMD) is a publicly traded Healthcare sector company. As of May 21, 2026, IRMD trades at $90.40 with a market cap of $1.13B and a P/E ratio of 47.84. IRMD moved +1.82% today. Year to date, IRMD is -8.04%; over the trailing twelve months it is +69.64%. Its 52-week range spans $46.86 to $107.90. Analyst consensus is buy with an average price target of $116.00. Rallies surfaces IRMD's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Which politicians traded IRMD stock?
Rallies tracks politician and congressional stock disclosures for IRMD, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
Rallies tracks politician and congressional stock disclosures for IRMD, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
Does Rallies track congressional trades in IRMD?
Yes. Rallies tracks politician and congressional stock disclosures for IRMD, including reported purchases, sales, dates, owners, and trade amounts when available.
Is IRMD research on Rallies investment advice?
No. Rallies provides research, data, and educational context for IRMD. It does not provide personalized investment advice.
